A case of early intrauterine parvovirus B19 infection

Prenatal Diagnosis

Volumn 16, Issue 1, 1996, Pages 75-77

  Brandenburg, H ^a,b   Los, F J ^a   Cohen Overbeek, T E ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiomyopathy; Elevated alpha fetoprotein in amniotic fluid; Intrauterine growth retardation; Parvovirus B19

Indexed keywords

ARTICLE; CASE REPORT; FETUS; HUMAN; INTRAUTERINE GROWTH RETARDATION; INTRAUTERINE INFECTION; PARVOVIRUS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; VIRUS INFECTION;

ADULT; ALPHA-FETOPROTEINS; AMNIOTIC FLUID; DNA, VIRAL; FEMALE; FETAL DISEASES; FETAL GROWTH RETARDATION; GLOMERULONEPHRITIS; HUMANS; MYOCARDITIS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

PARVOVIRUS;

EID: 0030030699     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199601)16:1<75::AID-PD803>3.0.CO;2-3     Document Type: Article

References (14)

1. Bernstein, I.M., Capeless, E.L. (1989). Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B19 infection, Obstet Gynecol., 74, 456-457.
2. Brown, C.S., Van Brussel, M.J.A., Wassenaar, A.L.M., Van Elsacker-Niele, A.W.M., Weiland, H.T., Salimans, M.M.M. (1990). An immunofluorescent assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen. J Virol Methods, 29, 53-62.
3. Currington, D., Whittle, M.J., Gibson, A.A.M., Brown, T., Field, A.M., Gilmore, D.H., Aitken, D., Patrick, W.J.A., Caul, E.O., Clewley, J.P., Cohen, B.J. (1987). Maternal serum α-fetoprotein - a marker of fetal aplastic crisis during mtrauterine human parvovirus infection, Lancet, i, 433-435.
4. Gloning, K.P., Schramm, T., Brusis, E., Schwarz, T., Roggendorf, M. (1990), Successful intrauterine treatment of fetal hydrops caused by parvovirus B19 infection, Behring Inst. Mitt, 85, 79-85.
5. Guidozzi, F., Ballot, D., Rothberg, A.D. (1994). Human parvovirus infection in an obstetric population. A prospective study determining fetal outcome, J. Reprod. Med., 39, 3608.
6. Hartwig, N.G., Vermey-Keers, C., Van Elsacker-Niele, A.M.W., Fleuren. G.J. (1989). Embryologic malformations in a case of intrauterine parvovirus B19 infection, Teratology. 39, 295-302.
7. Humphrey, W., Magoon, M., O'Shaughnessy, R. (1991). Severe nonimmune hydrops secondary to parvo B19 infection: spontaneous reversal in utero and survival of a term infant, Obstet. Gynecol, 78, 900-902.
8. Los, F.J., Hagenaars, A.M., Marrink. J., Cohen-Overbeek, T.E., Gaillard, J.L.J., Brandenburg, H. (1992). Maternal serum alpha-fetoprotein levels and fetal outcome in early second trimester oligohydramnios. Prenat. Diagn., 12, 285-292.
9. Peters, M.T., Nicolaides, K.H. (1990). Cordocentesis for the diagnosis of human parvovirus infection, Obstet. Gynecol., 75, 501-504.
10. Salimans, M.M.M. (1990). Detection of human parvovirus B19 DNA by dot-hybridisation and the polymerase chain reaction: applications for diagnosis of infections, Behring Inst. Mitt., 85, 39-45.
11. Sailer, D.N., Jr, Rogers, B.B., Canick, J.A. (1993). Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection, Prenat. Diagn., 13, 467-471.
12. Schwartz, T.F., Nerlich, A., Roggendorf, F.M. (1990). Parvovirus B19 infection in pregnancy. Behring Inst. Mitt., 85, 69-73.
13. Toftager-Larsen, K. (1990). Carbohydrate heterogeneity of human alpha-fetoprotein in pregnancy. Methodological and clinical studies. Dan. Med. Bull., 37, 41-57.
14. Towbin, J.A., Griffin, L.D., Martin, A.B., Nelson, S., Siu, B., Ayre, N.A., Demmler, G., Moise, K.J., Zhang, Y.H. (1994). Intrauterine adenoviral myocarditis presenting as nonimmune hydrops fetalis: diagnosis by polymerase chain reaction, Pediatr. Infect. Dis. J., 13, 144-150.